104 related articles for article (PubMed ID: 33892328)
1. Adiposity and the development of dyslipidemia in APOE ε2 homozygous subjects: A longitudinal analysis in two population-based cohorts.
Heidemann BE; Wolters FJ; Kavousi M; Gruppen EG; Dullaart RP; Marais AD; Visseren FL; Koopal C
Atherosclerosis; 2021 May; 325():57-62. PubMed ID: 33892328
[TBL] [Abstract][Full Text] [Related]
2. Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease.
Koopal C; van der Graaf Y; Asselbergs FW; Westerink J; Visseren FL;
Int J Obes (Lond); 2015 Feb; 39(2):265-9. PubMed ID: 24946908
[TBL] [Abstract][Full Text] [Related]
3. Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in ε2ε2 subjects.
Corsetti JP; Sparks CE; Bakker SJL; Gruppen EG; Dullaart RPF
Clin Biochem; 2018 Feb; 52():67-72. PubMed ID: 29157655
[TBL] [Abstract][Full Text] [Related]
4. Low prevalence of lipid metabolism abnormalities in APOE ε2-genotype and male patients 60 years or older with schizophrenia.
Ban C; Zhang Q; Feng J; Li H; Qiu Q; Tian Y; Li X
BMC Psychiatry; 2017 Dec; 17(1):399. PubMed ID: 29233125
[TBL] [Abstract][Full Text] [Related]
5. Severe Combined Dyslipidemia With a Complex Genetic Basis.
Le R; Abbas M; McIntyre AD; Hegele RA
J Investig Med High Impact Case Rep; 2019; 7():2324709619877050. PubMed ID: 31538826
[No Abstract] [Full Text] [Related]
6. Changes in adiposity modulate the APOA5 genetic effect on blood lipids: A longitudinal cohort study.
Lin H; Xuan L; Xiang J; Hou Y; Dai H; Wang T; Zhao Z; Wang S; Lu J; Xu Y; Chen Y; Wang W; Ning G; Bi Y; Li M; Xu M
Atherosclerosis; 2022 Jun; 350():1-8. PubMed ID: 35461093
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lys146-->Gln) are inefficiently converted to cholesterol-rich lipoproteins.
Mulder M; van der Boom H; de Knijff P; Braam C; van den Maagdenberg A; Leuven JA; Havekes LM
Atherosclerosis; 1994 Aug; 108(2):183-92. PubMed ID: 7980718
[TBL] [Abstract][Full Text] [Related]
8. Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.
Heidemann BE; Koopal C; Baass A; Defesche JC; Zuurbier L; Mulder MT; Roeters van Lennep JE; Riksen NP; Boot C; Marais AD; Visseren FLJ
Clin Genet; 2022 Oct; 102(4):253-261. PubMed ID: 35781703
[TBL] [Abstract][Full Text] [Related]
9. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.
Ferreira CN; Carvalho MG; Fernandes AP; Lima LM; Loures-Valle AA; Dantas J; Janka Z; Palotás A; Sousa MO
Neurochem Int; 2010 Jan; 56(1):177-82. PubMed ID: 19819279
[TBL] [Abstract][Full Text] [Related]
11. Genetic risk score in patients with the APOE2/E2 genotype as a predictor of familial dysbetalipoproteinemia.
Satny M; Todorovova V; Altschmiedova T; Hubacek JA; Dlouha L; Lanska V; Soska V; Kyselak O; Freiberger T; Bobak M; Vrablik M
J Clin Lipidol; 2024; 18(2):e230-e237. PubMed ID: 38044203
[TBL] [Abstract][Full Text] [Related]
12. Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study.
Martinelli N; Olivieri O; Shen GQ; Trabetti E; Pizzolo F; Busti F; Friso S; Bassi A; Li L; Hu Y; Pignatti PF; Corrocher R; Wang QK; Girelli D
BMC Med Genet; 2009 May; 10():41. PubMed ID: 19439088
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance involvement in prevalence of familial dysbetalipoproteinemia in ε2ε2 subjects by Bayesian network modeling.
Corsetti JP; Love TM; Sparks CE; Bakker SJL; Dullaart RPF
Clin Biochem; 2018 Sep; 59():31-36. PubMed ID: 29928902
[TBL] [Abstract][Full Text] [Related]
14. APOE genotype associates with food consumption and body composition to predict dyslipidaemia in Brazilian adults with normal-weight obesity syndrome.
Franco LP; Gonçalves Zardini Silveira A; Sobral de Assis Vasconcelos Lima R; Horst MA; Cominetti C
Clin Nutr; 2018 Oct; 37(5):1722-1727. PubMed ID: 28720344
[TBL] [Abstract][Full Text] [Related]
15. Association of apolipoprotein E polymorphism with plasma lipid disorders, independent of obesity-related traits in Vietnamese children.
Hanh NT; Nhung BT; Dao DT; Tuyet LT; Hop LT; Binh TQ; Thuc VT
Lipids Health Dis; 2016 Oct; 15(1):176. PubMed ID: 27724906
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E polymorphisms contribute to statin response in Chinese ASCVD patients with dyslipidemia.
Zhang L; He S; Li Z; Gan X; Li S; Cheng X; Yang N; Zheng F
Lipids Health Dis; 2019 Jun; 18(1):129. PubMed ID: 31153375
[TBL] [Abstract][Full Text] [Related]
17. ApoE epsilon2/epsilon3/epsilon4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome.
Olivieri O; Martinelli N; Bassi A; Trabetti E; Girelli D; Pizzolo F; Friso S; Pignatti PF; Corrocher R
Clin Exp Med; 2007 Dec; 7(4):164-72. PubMed ID: 18188530
[TBL] [Abstract][Full Text] [Related]
18. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
Insel PS; Hansson O; Mattsson-Carlgren N
JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
[TBL] [Abstract][Full Text] [Related]
19. Human plasma lipid modulation in schistosomiasis mansoni depends on apolipoprotein E polymorphism.
Martins da Fonseca CS; Pimenta Filho AA; dos Santos BS; da Silva CA; Domingues AL; Owen JS; Lima VL
PLoS One; 2014; 9(7):e101964. PubMed ID: 25051269
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
